PIERIS PHARMACEUTICALS INC (PIRS)
Institutional ownership reported to the SEC as of Q2 2025, across 25 quarters.
2
Reporting holders
$111
Reported value
0.0%
Held as options
-22
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Farther Finance Advisors, LLC | $68 | 3 | 0.00% | new | NEW |
| TWIN PEAKS WEALTH ADVISORS, LLC | $43 | 1 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 2 | $111 | 4 | 2 | 0 | 0 | 0.0% |
| Q3 2024 | 24 | $10.0M | 602,606 | 7 | 3 | 5 | 0.0% |
| Q2 2024 | 18 | $3.5M | 351,469 | 18 | 0 | 0 | 0.0% |
| Q1 2024 | 36 | $6.5M | 35,348,140 | 3 | 11 | 5 | 0.0% |
| Q4 2023 | 41 | $6.6M | 36,404,221 | 5 | 5 | 8 | 0.2% |
| Q3 2023 | 39 | $11.6M | 38,992,795 | 6 | 8 | 5 | 0.2% |
| Q2 2023 | 43 | $7.8M | 47,047,858 | 4 | 8 | 12 | 0.3% |
| Q1 2023 | 54 | $32.5M | 33,218,282 | 6 | 10 | 15 | 0.4% |
| Q4 2022 | 52 | $33.4M | 32,052,780 | 7 | 6 | 18 | 0.3% |
| Q3 2022 | 64 | $40.3M | 34,888,921 | 7 | 9 | 21 | 0.4% |
| Q2 2022 | 66 | $71.2M | 37,349,578 | 10 | 14 | 24 | 0.3% |
| Q1 2022 | 73 | $115.6M | 37,946,091 | 10 | 21 | 20 | 0.6% |
| Q4 2021 | 80 | $138.7M | 36,385,618 | 18 | 21 | 21 | 0.8% |
| Q3 2021 | 76 | $168.5M | 31,926,486 | 22 | 16 | 16 | 2.1% |
| Q2 2021 | 76 | $106.0M | 26,648,322 | 28 | 11 | 29 | 3.7% |
| Q1 2021 | 81 | $82.4M | 32,173,494 | 6 | 20 | 29 | 0.1% |
| Q4 2020 | 82 | $83.9M | 33,501,462 | 8 | 27 | 20 | 0.1% |
| Q3 2020 | 88 | $69.0M | 33,292,539 | 9 | 20 | 32 | 0.2% |
| Q2 2020 | 94 | $107.3M | 34,550,315 | 11 | 30 | 24 | 0.0% |
| Q1 2020 | 95 | $85.9M | 36,927,239 | 15 | 29 | 32 | 0.0% |
| Q4 2019 | 99 | $131.0M | 36,205,383 | 19 | 23 | 29 | 0.1% |
| Q3 2019 | 98 | $98.2M | 28,508,336 | 23 | 28 | 30 | 1.0% |
| Q2 2019 | 93 | $129.2M | 27,508,147 | 16 | 24 | 34 | 0.0% |
| Q1 2019 | 92 | $101.6M | 30,327,931 | 6 | 21 | 30 | 0.0% |
| Q4 2018 | 98 | $93.9M | 35,260,281 | 3 | 2 | 2 | 0.1% |